ICD10 code of POEMS syndrome and ICD9 code

The ICD-10 code for POEMS syndrome is D47.2 (Monoclonal gammopathy), while the legacy ICD-9 code used to categorize this condition was 273.1. Because POEMS syndrome is a rare multisystem disorder, it is often classified under broader hematological or plasma cell dyscrasia categories in coding systems.

What exactly is POEMS syndrome?

POEMS syndrome is a rare and complex paraneoplastic syndrome caused by an underlying plasma cell disorder. The name itself is an acronym representing the five primary features: Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal protein, and Skin changes. Patients often experience significant nerve damage, enlargement of organs such as the liver or spleen, hormonal imbalances, and various skin manifestations. Understanding the classification and coding of POEMS syndrome is essential for medical billing, insurance coverage, and ensuring that patients receive appropriate specialized care, as the disease requires a multidisciplinary approach involving hematologists, neurologists, and endocrinologists.

How is POEMS syndrome diagnosed and classified?

Diagnosis of POEMS syndrome is typically based on a set of major and minor criteria established by clinical consensus. Because it is a systemic condition, physicians look for the presence of a monoclonal plasma cell disorder (most commonly Lambda light chain) alongside polyneuropathy. The ICD-10 code D47.2 is often used because it encompasses monoclonal gammopathy, which is a hallmark diagnostic requirement for POEMS syndrome. Accurate coding is vital for tracking the clinical progression of the disease and facilitates access to high-cost targeted therapies such as VEGF-inhibitors or autologous stem cell transplantation.

What are the key clinical features of POEMS syndrome?

The clinical presentation of POEMS syndrome is highly variable, which is why diagnostic criteria rely on specific multisystem involvement. The following list highlights the primary components that define the syndrome:

• Polyneuropathy: Usually a chronic, progressive, symmetric sensorimotor demyelinating polyneuropathy.


• Organomegaly: Enlargement of the liver, spleen, or lymph nodes (hepatosplenomegaly or lymphadenopathy).


• Endocrinopathy: Dysfunction of the adrenal, thyroid, pituitary, gonadal, or pancreatic glands, often resulting in diabetes or hypothyroidism.


• Monoclonal protein: Detection of a monoclonal plasma cell proliferative disorder, almost exclusively IgA or IgG lambda.


• Skin changes: Includes hyperpigmentation, hypertrichosis (excessive hair growth), hemangiomas, and white nails (leukonychia).

Is POEMS syndrome considered a cancer?

While POEMS syndrome is not a standard "cancer" in the traditional sense, it is categorized as a plasma cell dyscrasia, meaning it involves the abnormal growth of plasma cells. It is closely related to other conditions like multiple myeloma. Because the condition is so rare, our community at DiseaseMaps.org, which includes 59 members living with this diagnosis, emphasizes the importance of consulting with hematology experts who are specifically familiar with the nuances of POEMS syndrome management. Proper medical coding ensures that patients are correctly identified within healthcare systems for specialized treatment protocols.

Next steps

• Consult a hematologist-oncologist who specializes in plasma cell dyscrasias or rare systemic diseases.


• Ensure your medical records accurately reflect the diagnosis to facilitate insurance approval for necessary diagnostic imaging (like skeletal surveys or PET scans).


• Connect with the 59 other members on DiseaseMaps.org to share experiences regarding symptom management and specialist recommendations.


• Inquire with your care team about clinical trials or registries that focus on long-term outcomes for patients with POEMS syndrome.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): POEMS syndrome overview.


• Orphanet: Rare disease database entry for POEMS syndrome (ORPHA:2910).


• OMIM (Online Mendelian Inheritance in Man): Entry #605225 regarding the molecular basis of plasma cell dyscrasias.


• PubMed: Clinical practice guidelines for the diagnosis and management of POEMS syndrome.